AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
71 hedge funds and large institutions have $232M invested in Accelerate Diagnostics in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $265M → $232M (-$33.3M)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Holders
71
Holding in Top 10
1
Calls
$3.51M
Puts
$3.86M
Top Buyers
| 1 | +$5.37M | |
| 2 | +$3.56M | |
| 3 | +$3.51M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.92M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.76M |
Top Sellers
| 1 | -$3.12M | |
| 2 | -$1.56M | |
| 3 | -$993K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$807K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$708K |